TrialDiabetes, obesity & metabolism2026

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials.

Sean Wharton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.